Juvenile myelomonocytic leukemia overview: Difference between revisions
(Created page with "{{Juvenile myelomonocytic leukemia}} {{CMG}} ==Overview== ==References== {{reflist|2}} {{Hematological malignancy histology}} {{SIB}} Category:Hematology [[Category:Ty...") |
m (Robot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
||
| (One intermediate revision by the same user not shown) | |||
| Line 3: | Line 3: | ||
==Overview== | ==Overview== | ||
'''Juvenile myelomonocytic leukemia (JMML)''' is a serious chronic [[leukemia]] (cancer of the blood) that affects children mostly aged 4 and under. The average age of patients at diagnosis is 2 years old. The World Health Organization has included JMML in the category of [[Myelodysplastic]] and [[Myeloproliferative]] disorders.<ref name="urlMyelodysplastic/Myeloproliferative Diseases Treatment - National Cancer Institute">{{cite web|url=http://www.cancer.gov/cancertopics/pdq/treatment/mds-mpd/HealthProfessional/page4 |title=Myelodysplastic/Myeloproliferative Diseases Treatment - National Cancer Institute |format= |work=}}</ref> The name JMML now encompasses all diagnoses formerly referred to as Juvenile Chronic Myeloid Leukemia (JCML), Chronic Myelomonocytic Leukemia of Infancy, and Infantile Monosomy 7 Syndrome. | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
{{Hematological malignancy histology}} | {{Hematological malignancy histology}} | ||
[[Category:Hematology]] | [[Category:Hematology]] | ||
Latest revision as of 16:39, 9 August 2012
|
Juvenile myelomonocytic leukemia Microchapters |
|
Differentiating Juvenile myelomonocytic leukemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Juvenile myelomonocytic leukemia overview On the Web |
|
American Roentgen Ray Society Images of Juvenile myelomonocytic leukemia overview |
|
Risk calculators and risk factors for Juvenile myelomonocytic leukemia overview |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Juvenile myelomonocytic leukemia (JMML) is a serious chronic leukemia (cancer of the blood) that affects children mostly aged 4 and under. The average age of patients at diagnosis is 2 years old. The World Health Organization has included JMML in the category of Myelodysplastic and Myeloproliferative disorders.[1] The name JMML now encompasses all diagnoses formerly referred to as Juvenile Chronic Myeloid Leukemia (JCML), Chronic Myelomonocytic Leukemia of Infancy, and Infantile Monosomy 7 Syndrome.